Caris Life Sciences (United States)

Recent papers from Caris Life Sciences (United States)

1. A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer CellsCancers · 2026
2. Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancerOncogene · 2026
3. Spatial Transcriptomics on a Diverse Pancreatic Cancer Cohort Reveals Race-Related Differences in Tumor Subtypes and Immune MicroenvironmentsCancer Research · 2026
4. Differential impact of tumor-derived ESR1 mutations on elacestrant benefit in metastatic breast cancerClinical Cancer Research · 2026
5. The conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trialNature Communications · 2026
6. The conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trialNature Communications · 2026
7. Case Report: Discordance between RNA-identified ETV6::RET and clinically reportable DNA profiling in salivary gland secretory carcinomaFrontiers in Oncology · 2026
8. Sinonasal POU2AF3 (COLCA2)-rearranged carcinomas: a study of 11 aggressive tumors with findings supporting classification as solid adenoid cystic carcinomaVirchows Archiv · 2026
9. Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancerCancer Cell · 2026
10. Pediatric Non‐Neural Granular Cell Tumor With Unexpected Molecular Identity: A Case That Challenges ClassificationPediatric Dermatology · 2026
11. 19 Dissecting ARNT Expression Patterns in RCC and Association with OutcomesThe Oncologist · 2026
12. Functionally active lymphoid aggregates correlate with improved prognosis in brain metastasesCancer Discovery · 2026
13. The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma ( NPC ) Differs by Somatostatin Receptor 2 ( SSTR2 ) ExpressionCancer Medicine · 2026
14. AI-driven resolution of uncertain histopathology in cases initially misdiagnosed as triple-negative breast cancernpj Breast Cancer · 2026
15. STK11 Mutations and Deletions Define an Aggressive Molecular Subgroup of Cervical AdenocarcinomaCancer Medicine · 2026
16. Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF V600E - or BRAF InsT -Mutant Brain Tumors: PNOC002JCO Precision Oncology · 2026
17. Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung CancerCancer Research Communications · 2026
18. Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancerThe Breast · 2026
19. Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinomaBritish Journal of Cancer · 2026
20. An Artificial Intelligence (AI) model integrating multiscale foundation model histopathology representations with molecular and clinical features predicts early and late distant recurrence in TAILORxnpj Breast Cancer · 2026